Jane Street
DMK

Jane Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Jane Street’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-576
Closed -$39K – 10997
2021
Q3 		$39K Buy
+576
New +$42.1K ﹤0.01% 9624

Other funds holding DMK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's DMK Position: Q1 2023 in Review

Jane Street sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2023, closing a stake of 1,383 shares — an estimated $16.4K sold.

Jane Street first reported a position in DMK in Q1 2014 and held it in 12 quarters. The position peaked at $103K in Q1 2014. 47 funds tracked by Wall St. Rank hold DMK as of Q1 2023.

  • Jane Street reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 1,383 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2023, an estimated $16.4K.
  • Jane Street first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 12 quarters.
  • Jane Street's DMK Pharmaceuticals Corporation Common Stock position peaked at $103K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.